The investment bank views Highfield as an attractive takeover target given its upside production potential, attractiveeconomics, well-developed Muga project, and strategic location. $5.30 is the upside price target.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025